{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T05:46:18Z","timestamp":1782279978800,"version":"3.54.5"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPB"],"published-print":{"date-parts":[[2026,6,23]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Cyperotundone (CYT), a vital component of Cyperus rotundus L., is\nknown to suppress tumor growth effectively. This investigation was performed to reveal the antibreast cancer(BC) effect of CYT and its mechanism.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>CCK-8 assay, colony formation, cell cycle\/apoptosis assays, and subcutaneous tumor\nmodel were used to investigate the anticancer effects of CYT. RNA sequencing was used to predict the targets of CYT, which were then verified by drug affinity responsive target stability\n(DARTS), cellular thermal shift assay (CETSA), and molecular docking. The pan-cancer analysis\non PLK1 was excavated by the comprehensive use of datasets from The Cancer Genome Atlas\n(TCGA) and Genotype-Tissue Expression Project (GTEx). Western blotting, immunohistochemical staining (IHC), and RT-qPCR were used to determine protein and gene levels. Pyruvate and\nlactate production assays were used to represent the glycolysis level.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>CYT inhibited the proliferation of BC cells, as well as causing apoptosis and\nblocking the cell cycle. In vivo, CYT decreased tumor regression without obvious toxicity. PLK1\nwas identified as a key target of CYT. High PLK1 expression was associated with early diagnostic value and poor survival of BC. Of note, PLK1 is positively correlated with glycolysis. CYT\ncan inhibit the key proteins of glycolysis and production of metabolites through the PTEN\/AKT\npathway in BC cells. In the rescue experiments, CYT significantly inhibited the overexpression of\nPLK1-induced elevation of glycolysis level<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>This is the first study to reveal the correlation between PLK1 and glycolysis and the\nregulation of glycolysis by PLK1 in TNBC cells. Although PLK1 was identified as a target of\nCYT, the research on how CYT exerts its anti-BC effect through PLK1 is still insufficient. Other\nmolecular pathways involved in CYT action, how disruption of glycolytic pathways contributes to\nits anticancer effects, and its potential compensatory mechanisms in cancer cells are needed to\nexplore.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>CYT is a potent PLK1 inhibitor that has an anticancer effect in BC cells by decreasing glycolytic function.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0113892010439840260417071159","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:44:22Z","timestamp":1782276262000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cyperotundone Regulates Polo-like Kinase 1-mediated Glycolysis to\nInhibit the Proliferation of Breast Cancer Cells"],"prefix":"10.2174","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2806-4340","authenticated-orcid":true,"given":"Xiaoyu","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Thyroid and Breast Diagnosis and Treatment Center, Affiliated Hospital of Shandong University ofTraditional Chinese Medicine, Jinan, China"},{"name":"First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Song","sequence":"additional","affiliation":[{"name":"Breast Cancer Center, Shandong Cancer Hospital and Institute, Shandong First MedicalUniversity and Shandong Academy of Medical Sciences, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Thyroid and Breast Diagnosis and Treatment Center, Affiliated Hospital of Shandong University ofTraditional Chinese Medicine, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Yu","sequence":"additional","affiliation":[{"name":"Breast Cancer Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Pharmaceutical Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892010439840260417071159","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/255496\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892010439840260417071159","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:47:27Z","timestamp":1782276447000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/255496\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":0,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113892010439840260417071159","relation":{},"ISSN":["1389-2010"],"issn-type":[{"value":"1389-2010","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-10-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-24","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}